Co-Authors
This is a "connection" page, showing publications co-authored by Paolo Gisondi and Alexander Egeberg.
Connection Strength
0.239
-
Low incidence rate of respiratory and viral infections over 5 years of treatment with tildrakizumab in patients with moderate-to-severe psoriasis: pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials. J Eur Acad Dermatol Venereol. 2021 Nov; 35(11):e709-e711.
Score: 0.239
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.